98 related articles for article (PubMed ID: 3411467)
1. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. II: Release rate behavior of tetracycline.
Azoury R; Elkayam R; Friedman M
J Pharm Sci; 1988 May; 77(5):428-31. PubMed ID: 3411467
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. I: Effect of casting solvent on hydration properties.
Azoury R; Elkayam R; Friedman M
J Pharm Sci; 1988 May; 77(5):425-7. PubMed ID: 3411466
[TBL] [Abstract][Full Text] [Related]
3. Real time MRI to elucidate the functionality of coating films intended for modified release.
Bernin D; Marucci M; Boissier C; Hjärtstam J; Olsson U; Abrahmsén-Alami S
J Control Release; 2019 Oct; 311-312():117-124. PubMed ID: 31454531
[TBL] [Abstract][Full Text] [Related]
4. Sustained release device containing metronidazole for periodontal use.
Golomb G; Friedman M; Soskolne A; Stabholz A; Sela MN
J Dent Res; 1984 Sep; 63(9):1149-53. PubMed ID: 6589279
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cellulose xanthate-metal-tetracycline complexes as a polymeric antibacterial agent with prolonged antibacterial activity.
Jung Y; Kim YM
Drug Deliv; 2008 Jan; 15(1):31-5. PubMed ID: 18197521
[TBL] [Abstract][Full Text] [Related]
6. Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose.
Larsson M; Hjärtstam J; Berndtsson J; Stading M; Larsson A
Eur J Pharm Biopharm; 2010 Nov; 76(3):428-32. PubMed ID: 20854907
[TBL] [Abstract][Full Text] [Related]
7. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage.
Chambin O; Champion D; Debray C; Rochat-Gonthier MH; Le Meste M; Pourcelot Y
J Control Release; 2004 Feb; 95(1):101-8. PubMed ID: 15013237
[TBL] [Abstract][Full Text] [Related]
8. Application of a local drug delivery system to periodontal therapy: I. Development of collagen preparations with immobilized tetracycline.
Minabe M; Uematsu A; Nishijima K; Tomomatsu E; Tamura T; Hori T; Umemoto T; Hino T
J Periodontol; 1989 Feb; 60(2):113-7. PubMed ID: 2656975
[TBL] [Abstract][Full Text] [Related]
9. Unfolding type gastroretentive film of Cinnarizine based on ethyl cellulose and hydroxypropylmethyl cellulose.
Verma S; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2014 Mar; 64():347-52. PubMed ID: 24370473
[TBL] [Abstract][Full Text] [Related]
10. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
Sarfraz MK; Rehman NU; Mohsin S
Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of counterion types on the sustained release characteristics of high-payload drug-ion complex: A case study on tetracycline hydrochloride.
Dong B; Hadinoto K
Eur J Pharm Sci; 2021 Jun; 161():105787. PubMed ID: 33684485
[TBL] [Abstract][Full Text] [Related]
12. Sustained drug release and electrochemical performance of ethyl cellulose-magnesium hydrogen phosphate composite.
Mohammad F; Arfin T; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():735-743. PubMed ID: 27987767
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of drugs from ethylcellulose--polyethylene glycol films and kinetics of drug release.
Samuelov Y; Donbrow M; Friedman M
J Pharm Sci; 1979 Mar; 68(3):325-9. PubMed ID: 34023
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of tripelennamine and other drugs dispersed in ethyl cellulose PEG films [proceedings].
Donbrow M; Samoelov Y
J Pharm Pharmacol; 1976 Dec; 28 Suppl():23P. PubMed ID: 12297
[No Abstract] [Full Text] [Related]
15. Investigation of dissolved cellulose in development of buccal discs for oromucosal drug delivery.
Yildir E; Sjöholm E; Preis M; Trivedi P; Trygg J; Fardim P; Sandler N
Pharm Dev Technol; 2018 Jun; 23(5):520-529. PubMed ID: 29067849
[TBL] [Abstract][Full Text] [Related]
16. Improved long term stability of aqueous ethylcellulose film coatings: importance of the type of drug and starter core.
Muschert S; Siepmann F; Cuppok Y; Leclercq B; Carlin B; Siepmann J
Int J Pharm; 2009 Feb; 368(1-2):138-45. PubMed ID: 18996457
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
[TBL] [Abstract][Full Text] [Related]
18. Sustained ophthalmic delivery of highly soluble drug using pH-triggered inner layer-embedded contact lens.
Zhu Q; Cheng H; Huo Y; Mao S
Int J Pharm; 2018 Jun; 544(1):100-111. PubMed ID: 29627356
[TBL] [Abstract][Full Text] [Related]
19. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
[TBL] [Abstract][Full Text] [Related]
20. Optimization and prediction of drug release from matrix tablets using response surface methodology and near infrared chemical imaging.
Bagchi S; Li W; Plakogiannis F
Pharm Dev Technol; 2012; 17(4):398-406. PubMed ID: 21222508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
